Refractory Merkel Cell Carcinoma
2 clinical trials · Condition
◉ Watch Refractory Merkel Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial (NCT05947500) | National Cancer Institute (NCI) | 2024-05-21 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625) | National Cancer Institute (NCI) | 2017-09-27 |
Track Refractory Merkel Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.